Framingham Heart Study | GenomeWeb

Framingham Heart Study

By combining genome-wide association and mRNA expression data, a National Heart, Lung, and Blood Institute-led team uncovered gene networks involved in blood pressure regulation.

An analysis in the Proceedings of the National Academy of Sciences suggests the association between obesity and an FTO gene variant became increasingly significant in the past several decades.

NEW YORK (GenomeWeb News) – Two studies appearing in the American Journal of Human Genetics today uncovered a handful of low-frequency variants, including novel variants in ANGPTL8, PNPLA5, and PCSK7, among others, that seem to contribute to cholesterol or lipid levels in the blood.

This story has been updated to correct a quote citing a BG official saying BNP is a marker of inflammation. In fact, he said that it was a marker of "loading and stretch."

The university will conduct studies of factors in predicting atrial fibrillation by using date from the Framingham Heart Study.

The collaboration is the first cooperative research-and-development agreement between FHS and a commercial partner in the study's 60-year history. It also marks the first time the study has ever used proteomics.

The collaboration with BG marks the first time the Framingham Heart Study has partnered with a commercial company on a CRADA project.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.